Le Lézard
Classified in: Health
Subject: EXE

An Alcohol-Free Pregnancy is the Best Choice for a Healthy Pregnancy


WASHINGTON, April 11, 2019 /PRNewswire/ -- In observance of April's Alcohol Awareness Month, the National Organization on Fetal Alcohol Syndrome (NOFAS) is raising awareness about the risk of prenatal alcohol exposure and fetal alcohol spectrum disorders (FASD). FASD is a set of lifelong physical, mental, and behavioral impairments that can occur in an individual prenatally exposed to alcohol.

NOFAS is also recognizing today's National Alcohol Screening Day (NASD). NASD is an outreach, education, and screening initiative that raises awareness about harmful and dependent drinking behaviors and connects individuals who are at risk with treatment options. NOFAS believes screening for alcohol use should be a part of a routine doctor visit so potential alcohol use disorders can be identified at an early stage.

NOFAS is urging attention to the risk of drinking during pregnancy and FASD because of the many misconceptions surrounding the topics. Some myths are that FASD is a rare disorder (it is not, up to one in 20 school-age children may have FASD), occasional drinking won't harm a baby (measurable harm might not occur in some offspring, but it might in others), third trimester drinking is safe (incorrect, disabilities can result from exposure at any stage of human development), experts disagree about whether pregnant women should abstain from alcohol (not true, all medical and health societies, research universities and institutes, federal and state agencies, and advocacy organizations like NOFAS advise abstinence from alcohol during pregnancy), and minority, lower socio-economic women with less education are more likely to have a child with an FASD (you guessed it, all false).

NOFAS understands that some might be resistant to any message to abstain from alcohol because drinking is part of their lifestyle. NOFAS President, Tom Donaldson says the advice to avoid alcohol when pregnant is not a finger-pointing warning or admonition, but an advisory grounded in the best available science. If each woman, and her partner, family, and friends, has access to accurate information, she can make the best decision for herself and her baby.

While most mothers-to-be in the US stop drinking, about 10 percent of pregnancies are exposed to some alcohol and three percent to binge drinking, highlighting the importance of public health messages and improved access to screening for risky alcohol use, including any alcohol use during pregnancy, and treatment for substance use disorders.  

NOFAS Media Director, Andy Kachor adds, "The lack of knowledge about the alcohol and pregnancy risk and the consequences of addiction are two reasons why screening for alcohol use disorders is essential, and why we need to get the information out to all audiences through all available media channels." He concludes, "Approximately half the pregnancies in the US are unplanned and many women don't know they are pregnant for the first few weeks or more, so abstaining from all alcohol while trying to get pregnant is the risk-free approach."

Contact: Tom Donaldson, [email protected]

 

SOURCE National Organization on Fetal Alcohol Syndrome


These press releases may also interest you

10 mai 2024
On May 10, 2024, the impactful international academic journal, Science Immunology, a sub-journal of Science, published a research paper titled "Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system...

10 mai 2024
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

10 mai 2024
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

10 mai 2024
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

10 mai 2024
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

10 mai 2024
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...



News published on and distributed by: